Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention
September 11, 2018
In this program, experts James Underberg, MD, MS (Chair), Alan Brown, MD, Peter Jones, MD, and Pamela Morris, MD present compelling presentations and cases focusing on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention.
CME 0.00 Credits
Fine-tuning the Management of Narcolepsy and Excessive Daytime Sleepiness in Obstructive Sleep Apnea
August 23, 2018
This program will focus on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates chaired by Michael Thorpy, MD with faculty Michael Sateia, MD; Thomas Scammell, MD,Kingman Strohl, MD; Phyllis Zee, MD, PhD
2.00 Credits
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
CME 2.00 Credits
Understanding Childhood Narcolepsy: Why it’s more than just a Sleepy Child
January 02, 2018
CME 1.00 Credits
Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series
January 01, 2018
An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol
CME 1.50 Credits
Demystifying Narcolepsy in Children: Pathways to Successful Outcomes
November 15, 2017
In this symposium, experts will address best practices in the diagnosis and treatment of narcolepsy, and explore hypersomnia mimics of narcolepsy in children.
CME 2.00 Credits
Heart Failure Management: Exploring Best Practices for the Internist
September 26, 2017
Experts Dr. Javed Butler and Dr. James Januzzi provide helpful insights on the topic of Heart Failure and offer best practices on heart failure management.
CME 1.50 Credits
Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea
August 09, 2017
In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP
No Credit Available
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
No Credit Available
The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies
November 08, 2016
In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.
No Credit Available
Optimizing Outcomes in the Management of Narcolepsy and Obstructive Sleep Apnea
October 25, 2016
In this program, Michael Thorpy, MD and Phyllis Zee, MD, provide state-of-the-art lectures, a stimulating panel discussion, and a provocative case study to address the challenges in the diagnosis of narcolepsy.
No Credit Available
Best Practices for Managing Narcolepsy and Obstructive Sleep Apnea: Evidence-Based Strategies and Solutions
June 13, 2016
Thomas Scammell, MD (Chair), Richard Bogan, MD, Michael Thorpy, MD, and Phyllis Zee, MD, PhD address the challenges in the diagnosis of narcolepsy, identify best practices, and assess current and emerging strategies for treatment of EDS in OSA.
No Credit Available